Myrtle S. Potter - 13 Jun 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Reporting relationship: Director
Issuer ticker: DNA
Reported as of: 13 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2024, 16:18:08 UTC
Prior SEC filing: 13 Jun 2024
Next SEC filing: 17 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Karen Tepichin, Attorney-in-Fact

Key filing fact

Myrtle S. Potter filed Form 4 for Ginkgo Bioworks Holdings, Inc. (DNA) on 14 Jun 2024.

Key facts

This page summarizes Myrtle S. Potter's Form 4 filing for Ginkgo Bioworks Holdings, Inc. (DNA).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 14 Jun 2024, 16:18.

Change

Previous filing in this sequence was filed on 13 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DNA transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +1,111,111
Change %
Price: $0.000000
Shares after: 1,111,111
Date: 13 Jun 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,111,111
Exercise price: $0.4620
Footnotes: F1, F2

DNA transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +571,428
Change %
Price: $0.000000
Shares after: 571,428
Date: 13 Jun 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 571,428
Exercise price: $0.4620
Footnotes: F3, F4

DNA transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +432,900
Change %
Price: $0.000000
Shares after: 432,900
Date: 13 Jun 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 432,900
Exercise price: $0.000000
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the initial option award as of the grant date is $400,000.

Footnote F2

The initial stock options shall vest and become exercisable in substantially equal installments on each of the first three anniversaries of the date of grant, such that the initial stock options shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.

Footnote F3

In accordance with the Non-Employee Director Compensation Program of the Issuer, the Black-Scholes value of the additional initial option award as of the grant date is $200,000.

Footnote F4

The vesting date of the RSUs and additional initial options, and in the case of the additional initial options, the exercise date, will be the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.

Footnote F5

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.